Lymph node clues may predict immunotherapy success in esophageal cancer
NCT ID NCT07573397
First seen May 11, 2026 · Last updated Jun 12, 2026 · Updated 7 times
Summary
This observational study aims to see if a specific type of immune cell (Tpex) found in cancer-free lymph nodes can predict whether esophageal cancer will completely respond to immunotherapy given before surgery. Researchers will study 88 people with esophageal cancer who are scheduled for surgery and immunotherapy. The goal is to find a better way to predict treatment success than current methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.